Published on
April 30, 2025
- 21:20 GMT
Liminatus Pharma and Iris Acquisition Corp Announce Completion of Business Combination
Liminatus (NASDAQ:LIMN) LA PALMA, CA, UNITED STATES, April 30, 2025 /EINPresswire.com/ -- Liminatus Pharma, LLC (“Liminatus” or the “Company”), a pre-clinical stage biopharmaceutical company developing novel, immune-modulating cancer therapies, and Iris …
Distribution channels:
Banking, Finance & Investment Industry
...
